Roger Adsett - 08 Mar 2022 Form 3 Insider Report for Landos Biopharma, Inc.

Role
Director
Signature
/s/ Eric W. Blanchard, attorney-in-fact
Issuer symbol
N/A
Transactions as of
08 Mar 2022
Net transactions value
$0
Form type
3
Filing time
10 Mar 2022, 15:18:20 UTC
Previous filing
13 Jan 2022
Next filing
13 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LABP No securities beneficially owned 0 08 Mar 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24.1 - Power of Attorney